Full text
Nab2p and the Thp1p-Sac3p Complex Functionally Interact at the Interface between Transcription and mRNA Metabolism* Received for publication, March 21, 2003, and in revised form, April 11, 2003 Published, JBC Papers in Press, April 17, 2003, DOI 10.1074/jbc.M302900200 Mercedes Gallardo‡§, Rosa Luna‡§, Hediye Erdjument-Bromage¶, Paul Tempst¶, and Andre´s Aguilera‡储 From the ‡Departamento de Gene´tica, Facultad de Biologı´a, Universidad de Sevilla, Avenida Reina Mercedes 6, 41012 Sevilla, Spain and the ¶Molecular Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021 THP1 is a conserved eukaryotic gene whose null mutations confer, in yeast, transcription and genetic instability phenotypes and RNA export defects similar to those of the THO/TREX complex null mutations. In a search for multicopy suppressors of the transcription defect of thp1⌬cells, we identified the poly(A) ⴙ RNA- binding heterogeneous nuclear ribonucleoprotein Nab2p. Multicopy NAB2 also suppressed the RNA export defect of thp1⌬cells. This result suggests a functional relationship between Thp1p and Nab2p. Consistently, the leaky mutation nab2-1 conferred a transcription defect and hyper-recombination phenotype similar to those of thp1⌬, although to a minor degree. Reciprocally, a purified His 6 -tagged Thp1p fusion bound RNA in vitro. In a different approach, we show by Western analyses that a highly purified Thp1p-Sac3p complex does not contain components of THO/TREX and that sac3⌬ confers a transcription defect and hyper-recombination phenotype identical to those of thp1⌬. mRNA degradation was not affected in thp1⌬mutants, implying that their expression defects are not due to mRNA decay. This indicates that Thp1p-Sac3p is a structural and functional unit. Altogether, our results suggest that Thp1p-Sac3p and Nab2p are functionally related heterogeneous nuclear ribonucleoproteins that define a further link between mRNA metabolism and transcription. In eukaryotes, the processing and export of mRNA from the nuclear transcription site to the cytoplasm require a large number of proteins, a fraction of which act cotranscriptionally. RNA polymerase II (pol II) 1 -driven transcription elongation is coupled with 5⬘-end capping, splicing, 3⬘-end cleavage, and poly(A) ⫹ addition (1, 2). Thus, capping enzymes access the 5⬘-end of nascent mRNAs via the pol II C-terminal domain; splicing occurs cotranscriptionally in association with the transcription elongation complex via the pol II C-terminal domain (3–6); and cleavage of the poly(A) ⫹ site is dependent on the pol II C-terminal domain (7). The connection between transcription and mRNA metabolism is supported by the accumulation of unspliced pre-mRNAs in mutants with a truncated pol II C-terminal domain (8) or the retention at the site of transcription of human  -globin pre-mRNAs defective in either splicing or 3⬘-end formation (9). This connection is also extended to mRNA export. The mRNA is not exported from the nucleus unless the transcript has been properly processed (10). Nuclear mRNA export seems to be connected to transcription at both functional and physical levels. It has been shown that hyperadenylated transcripts accumulate at the site of transcription after different mRNA export blockages (11). Importantly, a conserved TREX complex that contains Sub2p/UAP56, Yra1p/ALY, Tex1p, and the THO complex has been identified in yeast and humans (12). Yra1p/ALY and Sub2p/UAP56 are both involved in mRNA nuclear export (13). THO was previously identified as a four protein-containing complex involved in transcription elongation and the maintenance of genome stability (14). Yeast mutations in any of the four genes encoding the THO complex (THO2,HPR1,MFT1, and THP2) confer transcription elongation defects and a strong hyper-recombina- tion phenotype that is transcription-dependent (14–16). Functional analysis of sub2 and yra1 mutants as well as mex67 and mtr2 mutants, defective in the Mtr2p-Mex67p essential heterodimeric mRNA export factor (17, 18), revealed that they have defective transcription and high levels of transcriptiondependent direct-repeat recombination (19). All these factors represent a subset of conserved eukaryotic proteins involved in mature mRNA biogenesis and processing steps that are important for efficient transcription. Regardless of the specific function of these factors along the different steps of mRNA metabolism from 5⬘-end capping to 3⬘-end cleavage, poly(A) ⫹ addition, and export, failure to perform appropriately any of these steps may affect the other steps, leading to nuclear mRNA accumulation and transcription impairment and causing transcription-associated hyper-recombination. In a recent search for yeast mutants with high levels of genetic instability, we identified THP1, a gene conserved in eukaryotes whose null mutations confer the same transcription defect and hyper-recombination phenotype as those of THO mutants (20). To gain new insight into Thp1p function, we undertook two experimental approaches. First, in a search for multicopy suppressors of the gene expression defect of thp1⌬, we identified NAB2, a gene encoding an hnRNP that specifically associates with nuclear poly(A) ⫹ RNA in vivo (21) and is required for poly(A) tail length control and nuclear RNA export (22, 23). Second, we purified the Thp1p-Sac3p complex, which has also been purified in a parallel study (24); characterized it for the presence of components of the THO/TREX complex; and * This work was supported by Grant BMC2000-0439 from the Spanish Ministry of Science and Technology and Grant RG1999/0075 from the Human Frontier Science Program (to A. A.) and by NCI Grant CCSG P30 CA08748 from the National Institutes of Health (to P. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. § Both authors contributed equally to this work. 储To whom correspondence should be addressed. Tel.: 34-954-557-107; Fax: 34-954-557-104; E-mail: [email protected]. 1 The abbreviations used are: pol II, RNA polymerase II; hnRNP, heterogeneous nuclear ribonucleoprotein; mRNP, mRNA and heterogeneous nuclear ribonucleoprotein complex; HA, hemagglutinin; MALDI- reTOF, matrix-assisted laser desorption ionization reflectron time-of- flight; SC medium, synthetic complete medium; dsDNA, doublestranded DNA. THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 278, No. 26, Issue of June 27, pp. 24225–24232, 2003 © 2003 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. This paper is available on line at http://www.jbc.org 24225 This is an Open Access article under the CC BY license.
determined whether Thp1p-Sac3p acts as a functional unit in mRNP metabolism. Sac3p was first identified as an actin suppressor (25) and has been shown to be involved in nuclear protein export (26) and recently in RNA export (24, 27). We show by genetic and molecular analyses that sac3⌬and nab2-1 strains have transcription and hyper-recombination phenotypes similar to those of thp1⌬. In addition, we show that purified His 6 -Thp1p from Escherichia coli binds RNA in vitro. We conclude that Nab2p and Thp1p-Sac3p are functionally related hnRNP-like factors that act in the same process as THO/TREX and Mtr2p-Mex67p in mRNP metabolism. EXPERIMENTAL PROCEDURES Strains—We used the wild-type (W303-1A), hpr1⌬::HIS3 (U678-1C), tho2⌬::KAN (RK2-6C) (16), thp1⌬::KAN (WFBE046) (20), and mex67-5 (WMC1-1A) (19) strains that have been reported previously. Strain LSY267 (pep4⌬) (28) isogenic to W303-1A was used for protein complex purification. Mutant nab2-1 (22) is a nab2⌬strain carrying the nab2-1 mutant allele in a centromeric plasmid. The sac3⌬::KAN (Y03517) and thp1⌬::KAN (Y01764) strains were obtained from EUROSCARF (Frankfurt, Germany). Isogenic derivatives were obtained by genetic crosses. These include wild-type strains SAY3-2B, NAL-3A, and NAL-3B and mutant strains SAY3-2A (sac3⌬) and NAL-11B and NAL-5B (nab2-1). All comparative analyses were performed with mutants and their isogenic wild-type strains on either the W303 (R. Rothstein) or BY4741 (EUROSCARF) genetic background, with the exception of nab2-1, for which we used its own genetic background (22). Plasmids—Plasmids p416-GAL1-lacZ and pSCh202 (15), used for the studies of recombination and transcription, and plasmids YEp351- SUB2 (19) and pSUP38 (16) have been published previously. pRS316L⌬NS and pRS316L are identical to pRS314L⌬NS and pRS314L (29), but in vector pRS316. For the isolation of multicopy suppressors of thp1⌬, we used the pCM184-LAUR plasmid (19). We used MW90 constructed in YEp351 as a yeast multicopy library (30). For the purification of Thp1p from E. coli, we constructed plasmid pT7-HA-THP1 containing an N-terminal His 6 -HA-Thp1p translational fusion under the control of the T7 RNA polymerase promoter. For this purpose, the HA-THP1 fragment was obtained by PCR using primers GATATCATCGATCTCGAGTCACCAAAGAACGTGAG and GGATCCTCTAGAGCTAGCTATCCCTATGACGTTCCCTCTCACGTTTTGTGG- TCCATGGAAAAGAGAAG and subcloned into the NheI-ClaI site of plasmid pT7-7-His 6 (31). Purification of His 6 -HA-Thp1p from E. coli—E. coli strain BL21(DE3) transformed with plasmid pT7-HA-THP1 was grown in 1 liter of LB medium supplemented with 100 g/ml ampicillin up to A 600 ⫽0.8. Expression was induced for4hbyadding isopropyl-  -D- thiogalactopyranoside to a final concentration of 0.5 mM. Cells were lysed in buffer A (50 mMNaH 2 PO 4 and 300 mMNaCl, pH 8) containing 10 mMimidazole. His 6 -HA-Thp1 was partially purified by affinity chromatography on a nickel-nitrilotriacetic acid column (QIAGEN Inc.) in buffer A containing increasing concentrations of imidazole (20 and 250 mM). Thp1p-Sac3p Complex Purification and Western Analyses—The Thp1p-Sac3p complex was purified using a C-terminally TAP-tagged Thp1 protein constructed for this study. For this, we replaced the wild-type copy of THP1 with the THP1-TAP fusion obtained by PCR with primers GTTAATGAACGAATCACCAAGATGTTTCCTGCCCATTCTCACGTTTTGTGGTCCATGGAAAAGAGAAG and CAGCATAATGTCGCTCCTTCTCTTCTATTTCCTATATATATCTACGACTCACTAT- AGGG in wild-type strain LSY267. Purified TAP-tagged proteins were purified essentially as described (32) with modifications as published (19). Purified complexes were run on a 10% SDS-polyacrylamide gel and transferred to nylon membranes. After blocking with phosphatebuffered saline containing 0.1% Tween 20 and 5% milk, proteins were detected using antibodies against Mft1p and Sub2p and peroxidaseconjugated goat anti-rabbit IgG. Blots were washed with phosphatebuffered saline and 0.1% Tween 20 and developed by enhanced chemiluminescence reactions (ECL, Amersham Biosciences). Protein Identification—Gel-resolved proteins were digested with trypsin and partially fractionated, and the resulting peptide mixtures were analyzed by matrix-assisted laser desorption ionization reflectron time-of-flight (MALDI-reTOF) mass spectrometry (Reflex III, Bruker Daltonics, Bremen, Germany) as described (33) and also using an electrospray ionization triple quadrupole tandem mass spectrometry instrument (API300, ABI/MDS Sciex, Thornhill, Canada) modified with an ultrafine ionization source (34). Selected masses from the MALDI- reTOF spectra were taken to search the yeast segment of a protein non-redundant data base. Tandem mass spectra were inspected for y⬙ ion series to compare with the computer-generated fragment ion series of the predicted tryptic peptides. mRNA Export Assays—In situ mRNA localization assays were performed as described (35) using digoxigenin-labeled oligo(dT) 16 . In Vitro RNA and DNA Binding Assays—In vitro RNA and DNA band shifting assays were performed following the procedures described previously (19) using identical RNA and DNA probes. Miscellaneous—Recombination frequencies were obtained from two to three different transformants for each genotype. They were determined as the median frequency of 6–12 independent values for each transformant as reported previously (29).  -Galactosidase assays and Northern analyses were performed according to previously published procedures (15). RESULTS Multicopy NAB2 Suppresses the Gene Expression Defect of thp1⌬—To obtain new insights into the functional role of Thp1p, we searched for genes that could potentially have an overlapping function with Thp1p. For this, we used our newly developed genetic assays for the analysis of gene expression based on plasmid pCM184-LAUR carrying a 4.15-kb lacZ- URA3 translational fusion under the control of the P tet promoter (Fig. 1A) (19). We have previously reported that thp1⌬ mutants are defective in transcription of the lacZ sequence (20). Here, we first showed that, as expected, thp1⌬mutants containing the LAUR expression system were unable to form colonies on synthetic complete medium without uracil (SC⫺Ura) and showed reduced levels of  -galactosidase activity (Fig. 1B) (data not shown). From ⬃80,000 thp1⌬transformants with the multicopy library MW90 (30) plated on SC⫺Ura, we selected one that recovered the capacity to grow in the absence of uracil. Isolation and restriction and sequencing analysis of the plasmid (YEp351-1.9) carried by this transformant revealed a 6.5-kb insert of the NAB2 region covering three complete open reading frames. Complementation analysis of deletion derivative versions of the original plasmid indicated that the ability of this plasmid to suppress the gene expression defect of thp1⌬was abolished only if NAB2, but not the other two open reading frames, was deleted (data not shown). Subcloning of the NAB2 open reading frame into YEp351 confirmed that multicopy NAB2, and not the adjacent genes of the original insert, suppressed the inability of thp1⌬cells to express the lacZ-URA3 fusion as determined by growth on SC⫺Ura and by Northern analysis (Fig. 1, Band C). This suppression was specific to thp1⌬, and not to other mutants with the thp1-like phenotype such as hpr1⌬and tho2⌬(Fig. 1B). Quantification of mRNA levels showed that suppression of the transcription defect of thp1⌬cells was partial. Multicopy NAB2 made thp1⌬cells reach 11.6% of the wild-type levels of lacZ-URA3 expression. Finally, recombination analyses of the chromosomal directrepeat system leu2-k::ADE2-URA3::leu2-k showed that multicopy NAB2 reduced recombination in a thp1⌬background to levels (1.1 ⫻10 ⫺1 ) 1.5-fold below thp1 levels (7.1 ⫻10 ⫺2 ). These results indicate that suppression of thp1⌬by NAB2 overexpression is partial. It is detectable at the transcriptional level, but it is not enough to yield a significant effect on directrepeat recombination. Multicopy NAB2 Partially Suppresses the mRNA Export Defect of thp1⌬Mutants—Given the phenotypic similarity of thp1⌬mutants to mRNA export mutants and THO/TREX mutants (12, 19), we first showed, by in situ hybridization with digoxigenin-labeled oligo(dT) and fluorescein-conjugated antidigoxigenin antibody, that Thp1p was also required for proper mRNA nuclear export at both 30 and 37 °C (Fig. 1D) (data not shown). This is agreement with recently reported data from a parallel study (24). Consistent with this result, we observed Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing24226
that thp1⌬mex67-5 and sac3⌬mex67-5 double mutants were also inviable (data not shown), a phenotype previously observed for mutants that accumulate mRNA in the nucleus (18, 19, 36). Nab2p is a major nuclear protein associated with nuclear poly(A) ⫹ RNA (21) required for nuclear mRNA export (22, 23). As the transcription defect of thp1⌬was accompanied by mRNA accumulation in the nucleus, we assayed whether this phenotype was also suppressed by multicopy NAB2. As shown in Fig. 1D,thp1⌬cells carrying multicopy NAB2 showed significantly lower nuclear accumulation of poly(A) ⫹ RNA compared with thp1⌬cells, even though some nuclear mRNA accumulation could still be observed after4hofshifting cells to 37 °C. These results confirm that thp1⌬is suppressed by multicopy NAB2, but only at partial levels, and that the gene expression and mRNA export phenotypes are linked. nab2-1 Strains Are Defective in lacZ Transcription and Stimulate Direct-repeat Recombination—As our results showing that multicopy NAB2 suppresses thp1⌬suggest that the function of Nab2p might be related to that of Thp1p, we investigated whether nab2 mutants also show expression and recombination phenotypes similar to the those of thp1⌬mutants. Because NAB2 is an essential gene, we used nab2-1 for our studies. This mutation is leaky at 30 °C, and it was previously shown that nab2-1 strains accumulate mRNA in the nucleus at this temperature (22). As shown in Fig. 2A,nab2-1 reduced  -galactosidase activity to 20% of the wild-type levels. Kinetic analyses of transcription of the GAL1pr::lacZ and GAL1pr::PHO5 fusion constructs revealed that lacZ mRNA accumulated at a much slower rate than the wild-type strains, whereas only a small difference was found for PHO5. As shown for thp1⌬, this implies that the main transcription step impaired in nab2-1 mutants is transcription through lacZ, and not activation of the GAL1 promoter. Next, we determined the effect of nab2-1 on recombination between direct repeats. For this, we constructed nab2-1 strains carrying the chromosomal direct-repeat system leu2-k::ADE2-URA3::leu2-k containing two 2.16-kb repeat units. Recombination between the leu2-k repeats was scored in this system as deletions that lose the ADE2-URA3 intervening sequence plus one leu2-k copy. The frequency of deletions of nab2-1 strains was 25-fold above wildtype levels (Fig. 2B). The intensity of the phenotypes of nab2-1 was weaker than that of the phenotypes of thp1⌬, but this may be due to the leaky activity of the nab2-1 allele (22). To conclude, nab2-1 shows a transcription defect and hyperrecombination phenotype similar to those of thp1⌬, although to a lesser degree. mRNA Degradation Rates Are Unaffected in thp1⌬Mutants—The observation that transcription driven by the same promoter is defective in thp1⌬cells for some DNA sequences (i.e. lacZ), but not for others (i.e. PHO5), indicates that the transcription defect occurs at a post-initiation step (20). The fact that hyper-recombination of thp1⌬cells is linked to transcription elongation is good evidence that these mutants have a transcription defect responsible for hyper-recombination. Nevertheless, to confirm that the lower rate of mRNA formation observed in time course kinetic experiments is not due to high rates of mRNA decay caused by thp1⌬, we determined the degradation rate of two mRNAs, GAL1 and lacZ, driven by the same regulated GAL1 promoter. For this, we first allowed cells to accumulate mRNA in 2% galactose. After repressing transcription by shifting cells to 2% glucose, the kinetics of degradation of the accumulated mRNA was determined in time course experiments. Whereas thp1⌬strains formed the GAL1 mRNA at half the wild-type rate (20), Fig. 3 shows that the rate of degradation of this mRNA was not higher in thp1⌬versus wild-type cells (half-lives of 17 and 12 min, respectively). Also, whereas thp1⌬cells, in contrast to wild-type cells, did not form detectable lacZ mRNA after3hoftranscription activation (20), Fig. 3 shows that the rate of lacZ mRNA degradation was not higher in thp1⌬versus wild-type cells (half-lives of 7.5 and 4.5 FIG.1. Suppression of the transcription and mRNA export defects of thp1⌬by multicopy NAB2.A, scheme of the P tet ::lacZ-URA3 fusion construct carried by plasmid pCM184-LAUR. B, phenotypic analysis of the wild-type (WT; W303-1A), thp1⌬ (WFBE046), hpr1⌬(U678-1C), and tho2⌬(RK2-6C) strains carrying plasmid pCM184-LAUR and transformed with either vector YEp351 (YEp-) or plasmid YEp351-1.9 (YEp-1.9) containing NAB2. The capacity of each strain to form colonies on SC⫺Ura after 6 days at 30 °Cis shown. C, Northern analysis of the expression of the P tet ::lacZ-URA3 fusion construct. RNA was isolated from mid-log phase cells carrying pCM184-LAUR grown in SC medium. The 0.5-kb 5⬘-end lacZ BamHI- HpaI fragment and a 589-bp 25 S rDNA internal fragment obtained by PCR were used as DNA probes. Numbers below each lane indicate the percentage of the complete lacZ RNA with respect to the wild-type value, which was taken as 100%. Northern blots were quantified in a Fuji FLA 3000. D, subcellular localization of poly(A) ⫹ RNA analyzed by in situ hybridization with a digoxigenin-labeled oligo(dT) probe. Samples were taken from exponentially growing wild-type (W303-1A) and thp1⌬(WFBE046) cells transformed with multicopy plasmid YEp351 or YEp351-NAB2 that had been shifted to 37 °Cfor4hinSC⫺Leu. Nuclear DNA was stained with 10 g/ml 4,6-diamidino-2-phenylindole. All analyses were performed with as Olympus AHBT3 microscope. Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing 24227
min, respectively). We can therefore conclude that the strong defect in the kinetics of mRNA formation of thp1⌬cells is caused by defective transcription, and not by increased mRNA degradation. Thp1p Binds RNA in Vitro—Because null mutants of THP1 show phenotypes similar to those of mutants of the THO/TREX complex, Nab2p, and mRNA export factors Mtr2p and Mex67p, all of which bind RNA (17, 19, 21, 37), we investigated whether Thp1p associates with either RNA or DNA in vitro. We first purified His 6 -Thp1p from E. coli. RNA band shifting assays using a 90-nucleotide long RNA molecule showed that Thp1p bound RNA (Fig. 4A). Binding was directly proportional to the amounts of Thp1p used. No binding activity was observed with the negative control, i.e. purified material obtained from E. coli transformed with the empty vector pT7-7-His 6 . The ability to bind RNA is not conferred by the His 6 tail because we have shown that other His 6 -tagged proteins did not bind RNA in our assays. 2 RNA-binding activity competed strongly with unlabeled 2 A. G. Rondo´n and A. Aguilera, unpublished data. FIG.2. Expression analysis of GAL1pr::lacZ and GAL1pr::PHO5 constructs in nab2-1 mutants. A:upper panels,  -galactosidase and acid phosphatase activities of the wild-type (WT; NAL-3A) and nab2-1 (NAL-11B) strains transformed with plasmids p416-GAL1- lacZ and pSCh202. Each value represents the average of two to three different transformants. Only the data of induced expression (2% galactose) are given. Under repression conditions (2% glucose), values were below detection levels in all cases. Lower panels, Northern analysis of lacZ and PHO5 mRNAs driven by the GAL1 promoter. Mid-log phase cells transformed with plasmid p416-GAL1- lacZ or pSCh202 were diluted in 3% glycerol- and 2% lactate-containing SC⫺Ura to A 600 ⫽0.5 and incubated for 16 h at 30 °C. Galactose was then added, and samples were taken at different times as indicated. The 0.9-kb PHO5 EcoRV internal fragment was used as the PHO5 probe. For other details, see the legend to Fig. 1. B: recombination frequencies of the chromosomal direct-repeat system leu2-k::URA3-ADE2::leu2-k in the wildtype (NAL-3B) and nab2-1 (NAL-5B) strains. All experiments were performed at 30 °C. Recombination values are the median of a total of 12 independent colonies obtained from SC medium. Ura ⫺ recombinants were scored on SC medium containing 5-fluoroorotic acid. A.U., arbitrary units. Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing24228
RNA and weakly with unlabeled double-stranded DNA (dsDNA), but not with unlabeled single-stranded DNA (Fig. 4B). Direct DNA band shifting assays using a labeled 200-bp dsDNA showed that Thp1p bound dsDNA, but to a lesser degree compared with RNA (Fig. 4C). These results are in line with the functional analyses of thp1⌬mutants, suggesting that Thp1p is involved in RNA metabolism. The binding to dsDNA suggests the possibility that Thp1p may also act at sites of transcription, as has been shown for the Yra1p, Hpr1p and Tho2p components of the THO/TREX complex (12, 38). A Highly Purified Thp1p-Sac3p Complex Does Not Contain Components of the THO/TREX Complex—We constructed a yeast strain carrying the THP1-TAP gene fusion in which the TAP tag was fused to the C terminus of Thp1p at the chromosomal THP1 locus. We used the stringent tandem affinity purification method involving two sequential affinity purification steps (32) to purify yeast proteins that bound to Thp1p. Fractionation of the eluted fraction by SDS-PAGE and subsequent silver staining revealed three polypeptides with apparent molecular sizes of ⬃140, ⬃100, and ⬃50 kDa plus other minor bands (Fig. 5A). Peptide mass fingerprinting using MALDI- reTOF mass spectrometry and Sequence-Tag/PepFrag Database searching using limited amino acid sequence data obtained by electrospray ionization tandem mass spectrometry (33) revealed that p140 was Sac3p, that p100 was an N-termi- nal fragment of Sac3p, and that p50 was Thp1p. Therefore, we conclude that Thp1p and Sac3p tightly associate in yeast cells. These results are in agreement with a parallel study showing that Thp1p and Sac3p are associated in a complex (24). Sac3p is a nuclear protein export factor (26), trace amounts of which have recently been shown to copurify with TAP-tagged Sub2p (12). Given the possibility that the Thp1p-Sac3p complex could interact with THO/TREX, we determined whether small amounts of THO and Sub2p, not detectable on silver- FIG.3. Kinetics of degradation of GAL1 and lacZ mRNAs in thp1⌬mutants. Shown are the results from Northern analysis of the mRNA decay of the endogenous GAL1 mRNA and the lacZ mRNA driven by the GAL1 promoter in cells transformed with p416-GAL1-lacZ. Mid-log phase wild-type (WT; W303-1A) and thp1⌬(WFBE046) cells grown in 2% galactose-containing SC medium either for3h(GAL1) or overnight (lacZ) were transferred to 2% glucose-containing SC medium before samples were taken at the indicated times. The 0.75-kb GAL1 PvuII- AvaI internal fragment, the 3-kb lacZ BamHI-BglII fragment, and the 589-bp 25 S rRNA internal fragment obtained by PCR were used as 32 P-labeled DNA probes. FIG.4.In vitro RNA and DNA binding assays of purified His-Thp1p. A, RNA binding assay using the 90-bp 32 P-labeled RNA obtained from the pBluescript SK polylinker and increasing amounts of purified Thp1p from E. coli. Purified His-tagged extracts from E. coli transformed with the empty pT7-7-His 6 vector were used as negative controls. B, competition assays of the RNA-binding activity of Thp1p using as unlabeled competitors increasing amounts of the same 90-mer RNA used as probe, 60-mer single-stranded DNA (ssDNA), and 200-bp dsDNA. C, DNA binding assay using a 200-bp PCR-amplified 32 P-5⬘-end-labeled dsDNA and increasing amounts of purified Thp1p. Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing 24229
stained gels, were detectable by Western analysis with TAP- tagged Thp1p. Fig. 5Bshows that TAP-tagged Thp1p did not bring together either the Mft1p component of THO or Sub2p, indicating that most Thp1p-Sac3p complexes may be found in the cell independent of either THO or Sub2p. Interestingly, whereas multicopy SUB2 suppressed the transcription and recombination phenotypes of hpr1⌬, multicopy SUB2 caused lethality in thp1⌬strains. Multicopy THO2, which encodes the most prominent component of the THO complex, did not suppress thp1⌬(Fig. 5C). This reflects a putative functional relationship between Sub2p and Thp1p, which is different from the THO complex. sac3⌬Confers Transcription and Recombination Phenotypes Similar to Those of thp1⌬Mutants—To show that Thp1p-Sac3p acts as a functional unit, we performed a transcription and recombination analysis in sac3⌬mutants. In sac3⌬strains, expression of the bacterial lacZ sequence under the control of the GAL1 promoter was almost abolished. Kinetic analysis of transcription activation of sac3⌬mutants showed an undetectable accumulation of lacZ mRNA for 170 min after activation (Fig. 6A). When an identical experiment was performed with a GAL1pr::PHO5 fusion, accumulation of PHO5 mRNA occurred with the same kinetics as the wild-type strain, reaching similar levels of transcription after 170 min of activation (Fig. 6A). These results are similar to those previously reported for thp1⌬ (20) and suggest that transcription elongation through lacZ, and not activation of the GAL1 promoter, is impaired in sac3⌬ strains. Analysis of recombination in the direct-repeat system leu2-k::ADE2-URA3::leu2-k revealed that sac3⌬increased the frequency of recombination 2145-fold above wild-type levels (Fig. 6B), a result similar to that previously obtained for thp1⌬ (20). To determine whether the hyper-recombination phenotype of sac3⌬strains was dependent on transcription of the intervening sequence located between the repeats, we determined the effect of sac3⌬on recombination in the plasmid repeat systems L and LY⌬NS. These systems are based on a 0.6-kb leu2 repeat that contains either no intervening sequence or a 5.16-kb long one. In both cases, transcription was initiated from the external LEU2 promoter and proceeded through the intervening region (29). As shown in Fig. 6B, whereas recombination frequencies in the L systems were the same in the sac3⌬and wild-type strains, recombination was increased 10- fold in the LY⌬NS system. As previously shown for thp1⌬(20), these results are consistent with the idea that transcription of an intervening DNA sequence such as that in LY⌬NS is required for hyper-recombination in sac3⌬mutants. DISCUSSION In this study, we have shown that the Thp1p-Sac3p complex is functionally related to the major mRNA-binding protein Nab2p and functions in the interface between transcription and mRNP metabolism. We link for the first time the functions of Sac3p and Nab2p, two proteins previously known to be involved in either protein or mRNA nuclear export, with transcription efficiency. Thp1p-Sac3p and Nab2p are functionally related factors that act in the same biological process as THO/ TREX and Mtr2p-Mex67p, linking transcription and mRNP metabolism and affecting genome instability. Thp1p is a conserved eukaryotic protein identified by the ability of null mutants to stimulate transcription-dependent hyper-recombination (20). Sac3p is a nuclear protein first identified as an actin suppressor (25) and is required for export of nuclear export signal-containing proteins (26). Thp1p-Sac3p behaves as a functional unit, as suggested by the thp1⌬and sac3⌬identical phenotypes of transcription impairment of lacZ sequences, transcription-dependent hyper-recombination, and defective mRNA nuclear export (Fig. 6) (20, 24). There are many phenotypic similarities between the mutants of Thp1p- Sac3p and the THO/TREX complex. However, THO/TREX and Thp1p-Sac3p are different complexes because, upon Western analysis, we found neither Sub2p nor Mft1p in the purified Thp1p-Sac3p complex (Fig. 5, Aand B). Our observation that overexpression of Sub2p confers lethality on thp1⌬mutants indicates that Sub2p and Thp1p-Sac3p may functionally interact. Indeed, Sac3p copurifies with a Sub2p-TAP fusion (12). This interaction occurs apart from the THO complex because Sac3p is not copurified with TAP fusions of the THO components (12, 19). The specific functions of the THO and Thp1p- Sac3p complexes may be different. In favor of this conclusion are the observations that whereas multicopy SUB2 suppresses the transcription and recombination phenotypes of hpr1⌬(19, FIG.5.Purification and analysis of the Thp1p-Sac3p complex. A, silver-stained SDS-polyacrylamide gel of the TAP-tagged Thp1p complex purified from yeast pep4⌬cells (LSY267). The lower abundance protein, indicated by an asterisk, corresponds to Cdc31p, which belongs to the superfamily of calmodulin proteins with a putative ability to bind the calmodulin-binding site of TAP. Lane M, molecular mass markers. B, Western blots of Thp1p-TAP- and Tho2p-TAP-purified complexes from the wild-type (WT), sub2⌬, and mft1⌬strains using anti-Sub2p and anti-Mft1p antibodies. Neither Sub2p nor Mft1p was detected in the Thp1p-Sac3p complex. C, effect of multicopy SUB2 and THO2 on cell viability of a thp1⌬ strain. The wild-type (W303-1A) and thp1⌬(WFBE046) strains were transformed with the URA3-based pRS416-THP1 plasmid, containing a wild-copy of THP1, plus the LEU2-based YEp351 multicopy plasmid, containing a wild-copy of either SUB2 (YEp-SUB2)orTHO2 (YEp-THO2). Transformants diluted by factors of 10 were plated on SC⫺Leu containing 500 g/ml 5-fluoroorotic acid. Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing24230
39), multicopy SUB2 causes lethality in the thp1⌬genetic background (Fig. 5C). Nab2p is an RNA-binding hnRNP that strongly and specifically associates with nuclear poly(A) ⫹ RNA in vivo (21) and is required for poly(A) ⫹ tail length control and nuclear export of mRNA (22, 23). Our observations that multicopy NAB2 suppresses the transcription and mRNA export defects of thp1⌬ (Fig. 1D) and that nab2-1 confers a similar inability to transcribe lacZ sequences and hyper-recombination phenotype compared with thp1⌬(Fig. 2) suggest that Nab2p and Thp1p- Sac3p function in the same biological pathway as THO/TREX, Mex67p, and Mtr2p. Consistently, it has recently been shown that Sac3p physically interacts with Mex67p, Mtr2p, and Mlp1p (24, 27) and that Mlp1p interacts with Nab2p (40). In this study, we have shown that the defect in the kinetics of transcript formation observed in the mutants of the Thp1p- Sac3p complex (Fig. 6A) (20) is not due to increased mRNA decay (Fig. 3), in contrast to what had been suggested for other mutants of mRNP metabolism (41, 42). The degradation rates of transcripts such as lacZ and GAL1, which are formed at different rates, are lower in thp1 versus wild-type cells (Fig. 3). Therefore, the lower accumulation rate of particular mRNAs such as lacZ is mainly the consequence of defective transcription and consistent with the increase in recombination mediated by transcription impairment. Most (if not all) mRNAs are associated with hnRNPs and are exported through the nuclear pore complex as mRNPs. During mRNA export, it is likely that proteins bound to the mRNA act as adapters for export factors to be translocated through the nuclear pore complex. In this sense, Nab2p is a classic shuttling hnRNP that requires ongoing transcription of poly(A) ⫹ RNA for its export from the nucleus. Preliminary results suggest that Mex67p is required for such an export (22). Thp1p- Sac3p interacts with Mex67p, Mtr2p, and other factors involved in mRNA export (24, 27). SacIII physically interacts with nucleoporins (24, 26), and it has been proposed that Sac3p mediates recruitment of the mRNA export machinery to the nuclear pore complex through this interaction (24). Thp1p and Sac3p have nuclear pore locations, which are dependent on the Nup1p nucleoporin (24). It has been shown by immunoelectron microscopy that Sac3p localizes to the cytoplasmic fibrils of the nuclear pore complex (27). In addition, Thp1p contains at least one leucine-rich nuclear export signal (LNYMIPTGLIL) starting at amino acid 268. Nuclear export signals were found in FIG.6. Transcription and recombination analyses of sac3⌬mutants. A, Northern analysis of lacZ and PHO5 mRNAs driven by the GAL1 promoter in the wild-type (WT; BY4741) and sac3⌬ (Y03517) strains transformed with plasmid p416-GAL1-lacZ or pSCh202. Mid-log phase cells were diluted in 3% glycerol- and 2% lactate-containing SC⫺Ura to A 600 ⫽0.5 and incubated for 16 h at 30 °C. Galactose was then added, and samples were taken at different times as indicated. For details, see the legend to Fig. 2. B, recombination frequency of the chromosomal direct-repeat system LUA (leu2-k::URA3-ADE2::leu2-k) in the wildtype (SAY3-2B) and sac3⌬(SAY3-2A) strains and of plasmid direct-repeat recombination systems L and LY⌬NS in the wild-type (BY4741) and sac3⌬(Y03517) strains transformed with pRS316L and pRS316L⌬NS, respectively. A scheme of each direct-repeat recombination system is shown. Recombination values are the median of a total of 12 independent colonies obtained from SC medium (LUA) or SC⫺Ura (L and LY⌬NS). Ura ⫺ (LUA) and Leu ⫹ (L and LY⌬NS) recombinants were scored on SC medium containing 5-fluo- roorotic acid and on SC⫺Leu⫺Ura, respectively. Arrows indicate transcripts. Recombination values are the median of 12 independent colonies obtained from either SC complete medium. A.U., arbitrary units. Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing 24231
several proteins that shuttle between the nucleus and the cytoplasm (43). In most cases, nuclear export signal-containing proteins are RNA-binding proteins that act as adapters and thus could be involved in the export of their cognate cargo RNA. Thp1p indeed has the ability to bind RNA in vitro (Fig. 4). Therefore, a possibility yet to be tested is whether the mRNA export defect observed in thp1⌬,sac3⌬, and even nab2-1 mutants could be caused by the inability of the export machinery to contact hnRNPs absent in improperly assembled or processed mRNPs. Given the increasing evidence of the connection between transcription, mRNA maturation, termination, and export (1, 2, 44, 45), it is likely that failure to perform a particular step during mRNP biogenesis has direct consequences on both upstream (i.e. transcription) and downstream (i.e. RNA export) steps. Thus, an mRNP is not exported from the nucleus unless the transcript has been properly processed (10). This could be the case for mutants of the THO/TREX complex (19). Reciprocally, there are indications that mRNA export blockage leads to accumulation of transcripts at the site of transcription (11). Regardless of the step of mRNP metabolism in which Thp1p- Sac3p and Nab2p function, it would be interesting to know whether mutations in their genes could lead to an accumulation of improperly formed mRNP intermediates at the site of transcription, promoting transcription impairment responsible for hyper-recombination. The transcription-associated hyper-recombination phenotype of thp1⌬,sac3⌬, and nab2-1 mutants is common to other mutants affected in both mRNP biogenesis and transcription (19, 46), but it is not observed in mutants of bona fide transcription elongation factors such as spt4⌬(47). We believe that failure to properly process or form the nascent mRNP molecules could lead to reactive nascent mRNA molecules that could interact with the DNA template located behind the advancing RNA polymerase, creating intermediates (i.e. RNA/DNA hybrids) responsible for both the elongation defect of the next elongating pol II and the increase in recombination, as we have previously proposed (46). Further biochemical and cell biology analyses are required to solve the molecular basis of this connection. Acknowledgments—We thank L. Lacomis for help with protein identification; E. Hurt and T. Lithgow for antibodies; B. Seraphin for providing the TAP vector system; A. H. Corbett for the nab2-1 strain; J. de la Cruz, S. Jimeno, P. Huertas, and A. G. Rondo´n for critical reading of the manuscript; and D. Haun for style supervision. REFERENCES 1. Hirose, Y., and Manley, J. L. (2000) Genes Dev. 14, 1415–1429 2. Proudfoot, N. J., Furger, A., and Dye, M. J. (2002) Cell 108, 501–512 3. Mortillaro, M. J., Blencowe, B. J., Wei, X., Nakayasu, H., Du, L., Warren, S. L., Sharp, P. A., and Berezney, R. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 8253–8257 4. Steinmetz, E. J. (1997) Cell 89, 491–494 5. Vincent, M., Lauriault, P., Dubois, M. F., Lavoie, S., Bensaude, O., and Chabot, B. (1996) Nucleic Acids Res. 24, 4649–4652 6. Yuryev, A., Patturajan, M., Litingtung, Y., Joshi, R. V., Gentile, C., Gebara, M., and Corden, J. L. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6975–6980 7. McCracken, S., Fong, N., Yankulov, K., Ballantyne, S., Pan, G., Greenblatt, J., Patterson, S. D., Wickens, M., and Bentley, D. L. (1997) Nature 385, 357–361 8. Misteli, T., and Spector, D. L. (1999) Mol. Cell 3, 697–705 9. Custodio, N., Carmo-Fonseca, M., Geraghty, F., Pereira, H. S., Grosveld, F., and Antoniou, M. (1999) EMBO J. 18, 2855–2866 10. Zenklusen, D., and Stutz, F. (2001) FEBS Lett. 498, 150–156 11. Jensen, T. H., Patricio, K., McCarthy, T., and Rosbash, M. (2001) Mol. Cell 7, 887–898 12. Strasser, K., Masuda, S., Mason, P., Pfannstiel, J., Oppizzi, M., Rodriguez- Navarro, S., Rondo´n, A. G., Aguilera, A., Struhl, K., Reed, R., and Hurt, E. (2002) Nature 417, 304–308 13. Reed, R., and Hurt, E. (2002) Cell 108, 523–531 14. Cha´vez, S., Beilharz, T., Rondo´n, A. G., Erdjument-Bromage, H., Tempst, P., Svejstrup, J. Q., Lithgow, T., and Aguilera, A. (2000) EMBO J. 19, 5824–5834 15. Cha´vez, S., and Aguilera, A. (1997) Genes Dev. 11, 3459–3470 16. Piruat, J. I., and Aguilera, A. (1998) EMBO J. 17, 4859–4872 17. Santos-Rosa, H., Moreno, H., Simos, G., Segref, A., Fahrenkrog, B., Pante, N., and Hurt, E. (1998) Mol. Cell. Biol. 18, 6826–6838 18. Segref, A., Sharma, K., Doye, V., Hellwig, A., Huber, J., Luhrmann, R., and Hurt, E. (1997) EMBO J. 16, 3256–3271 19. Jimeno, S., Rondo´n, A. G., Luna, R., and Aguilera, A. (2002) EMBO J. 21, 3526–3535 20. Gallardo, M., and Aguilera, A. (2001) Genetics 157, 79–89 21. Anderson, J. T., Wilson, S. M., Datar, K. V., and Swanson, M. S. (1993) Mol. Cell. Biol. 13, 2730–2741 22. Green, D. M., Marfatia, K. A., Crafton, E. B., Zhang, X., Cheng, X., and Corbett, A. H. (2002) J. Biol. Chem. 277, 7752–7760 23. Hector, R. E., Nykamp, K. R., Dheur, S., Anderson, J. T., Non, P. J., Urbinati, C. R., Wilson, S. M., Minvielle-Sebastia, L., and Swanson, M. S. (2002) EMBO J. 21, 1800–1810 24. Fischer, T., Strasser, K., Racz, A., Rodriguez-Navarro, S., Oppizzi, M., Ihrig, P., Lechner, J., and Hurt, E. (2002) EMBO J. 21, 5843–5852 25. Novick, P., Osmond, B. C., and Botstein, D. (1989) Genetics 121, 659–674 26. Jones, A. L., Quimby, B. B., Hood, J. K., Ferrigno, P., Keshava, P. H., Silver, P. A., and Corbett, A. H. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 3224–3229 27. Lei, E. P., Stern, C. A., Fahrenkrog, B., Krebber, H., Moy, T. I., Aebi, U., and Silver, P. A. (2003) Mol. Biol. Cell 14, 836–847 28. Symington, L. S. (1991) EMBO J. 10, 987–996 29. Prado, F., Piruat, J. I., and Aguilera, A. (1997) EMBO J. 16, 2826–2835 30. Waldherr, M., Ragnini, A., Jank, B., Teply, R., Wiesenberger, G., and Schweyen, R. J. (1993) Curr. Genet. 24, 301–306 31. Clever, B., Intherthal, H., Schmuckli-Maurer, J., King, J., Sigrist, M., and Heyer, W. D. (1997) EMBO J. 16, 2535–2544 32. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., and Seraphin, B. (1999) Nat. Biotechnol. 17, 1030–1032 33. Erdjument-Bromage, H., Lui, M., Lacomis, L., Grewal, A., Annan, R. S., McNulty, D. E., Carr, S. A., and Tempst, P. (1998) J. Chromatogr. A. 826, 167–181 34. Geromanos, S., Frecklenton, G., and Tempst, P. (2000) Anal. Chem. 72, 777–790 35. Amberg, D. C., Goldstein, A. L., and Cole, C. N. (1992) Genes Dev. 6, 1173–1189 36. Strasser, K., Bassler, J., and Hurt, E. (2000) Cell Biol. 150, 695–706 37. Strasser, K., and Hurt, E. (2001) Nature 413, 648–652 38. Lei, E. P., Krebber, H., and Silver, P. A. (2001) Genes Dev. 15, 1771–1782 39. Fan, H. Y., Merker, R. J., and Klein, H. L. (2001) Mol. Cell. Biol. 21, 5459–5470 40. Green, D. M., Johnson, C. P., Hagan, H., and Corbett, A. H. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 1010–1015 41. Libri, D., Dower, K., Boulay, J., Thomsen, R., Rosbash, M., and Jensen, T. H. (2002) Mol. Cell. Biol. 22, 8254–8266 42. Zenklusen, D., Vinciguerra, P., Wyss, J. C., and Stutz, F. (2002) Mol. Cell. Biol. 22, 8241–8253 43. Gerace, L. (1995) Cell 82, 341–344 44. Birse, C. E., Minvielle-Sebastia, L., Lee, B. A., Keller, W., and Proudfoot, N. J. (1998) Science 280, 298–301 45. Hammell, C. M., Gross, S., Zenklusen, D., Heath, C. V., Stutz, F., Moore, C., and Cole, C. N. (2002) Mol. Cell. Biol. 22, 6441–6457 46. Aguilera, A. (2002) EMBO J. 21, 1–7 47. Rondo´n, A. G., Garcı´a-Rubio, M., Gonza´lez-Barrera, S., and Aguilera, A. (2003) EMBO J. 22, 1–9 Nab2p and Thp1p-Sac3p in mRNP Biogenesis and Processing24232